Skip to main content
MGRX
NASDAQ Life Sciences

Mangoceuticals Seeks Up to $10M in Tokenized 8% Preferred Stock Sale

Tom Rudovsky · Reported by Wiseek News
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.208
Mkt Cap
$4.429M
52W Low
$0.162
52W High
$2.28
52W Position info
28% above low
Off High info
91% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

MGRX sits 28% above its 52-week low of $0.162 on light trading volume (0.3× avg).

Summary

Mangoceuticals filed a Form 1-A offering statement to sell up to 1.0M shares of a new 8% Series D convertible preferred at $10.00 each, targeting up to $10M gross, with SEC qualification still pending. No common stock is issued at closing and conversion can't begin for three years, so near-term dilution is deferred. The raise is large relative to a company with a roughly $4.4M market cap and $229K of cash at the last 10-Q, which carried a going concern warning and Nasdaq bid-price risk. This follows the Nov 6 8-K in which the sole Series B holder approved the Series D, and the Nov 6 proxy seeking a 1-for-2 up to 1-for-25 reverse split to cure the bid-price deficiency. The company bills it as the first Nasdaq-listed tokenized preferred stock offering, on the t7x platform. Watch SEC qualification of the offering statement and the shareholder vote on the reverse split.

At the time of this announcement, MGRX was trading at $0.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $0.16 to $2.28. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1761 info
Change: -$0.0139 (-7%) info
Market Cap: $4.112M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1761 info
Change: -$0.0139 (-7%) info
Market Cap: $4.112M info
MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.1761 info
Change: -$0.2539 (-59%) info
Market Cap: $4.112M info
MGRX
Oct 09, 2026, 4:00 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4251
Real-time Price: $0.1761 info
Change: -$0.249 (-59%) info
Market Cap: $4.112M info
MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.1761 info
Change: -$0.2346 (-57%) info
Market Cap: $4.112M info